News

Scientists have identified a drug candidate to restore heart muscle function following a heart attack. Currently, no drug exists to restore heart muscle function after a heart attack.

A small protein that could protect the brain from stroke-induced injury has been discovered by researchers from The University of Queensland and Monash University.

A new UCLA study could change scientists' understanding of how the brain works—and could lead to new approaches for treating neurological disorders and for developing computers that "think" more like humans.

As I start to look at the emerging trends of 2017 from the vantage of IndieBio, where we see hundreds of biotech startup applications and technologies per year, a few key themes are already emerging. Even as political landscapes change, science and technology continue to push forward.

Looking for a fountain of youth? You may need to search no further than your sneakers. Exercise, particularly high-intensity interval training, encourages your cells to make more proteins to feed their energy-producing machinery -- and this arrests the aging process, according to a new study published Tuesday in the journal Cell Metabolism.

As we age, some systems in the body don’t work as well. Eyesight weakens, there can be some minor age related memory loss and many people move a little slower and don’t stay as active. Sleep disturbances are common as well, but recent research shows that sleeping patterns could be an indicator of another problem seen in the elderly: dementia. Currently estimates put the number of people dealing with some form of dementia at about 46 million globally. In the United States, there are approxima...

(Minds) Bioquark, a biotech company based in the United States, has been given the go-ahead to begin research on 20 brain-dead patients, in an attempt to stimulate and regrow neurons and, literally, bring the patients back from the dead.

The Allen Institute for Brain Science is releasing new, highly realistic computer models of neurons. The models were developed using tools and expertise from the Blue Brain Project.

Scientists reveal that the combination of two molecular signals determines which cells that have already differentiated can regain their stem cell properties.

A new study shows that the act of creating pluripotent stem cells for clinical use is unlikely to pass on cancer-causing mutations to patients.